Skip to main content
Fig. 6 | Virology Journal

Fig. 6

From: Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0

Fig. 6

Bland Altman Plot: Aptima vs Roche. The figure shows results quantifiable in both the Aptima and Roche assays in log IU/mL for 608 positive clinical specimens. Bland-Altman analysis was conducted comparing the difference between the Aptima and Roche assays against the average result for the two assays for each specimen. The average bias was 0.11 log IU/mL with 95% acceptability limits of −0.56 to 0.78 log IU/mL

Back to article page